Pharmacokinetics [phsf]
Clinical evaluation [hlca]
alogliptin [orch, phsu]
Plus [qlco]
pioglitazone [orch, phsu]
Combination [qlco]
Type 2 Diabetes [dsyn]
Introduction [hlca]
Type 2 Diabetes [dsyn]
Complex [qlco]
Multiple [qnco]
defects [ftcn]
Combination [qlco]
Several [qnco]
Pharmacological [bmod]
Approaches [spco]
Reach [orgf]
GLUCOSE CONTROL [irda]
Target [ftcn]
Unique [qlco]
Fixed [fndg]
Dose [qnco]
Combination [qlco]
Combine [mnob]
thiazolidinedione [orch, phsu]
pioglitazone [orch, phsu]
Dipeptidyl Peptidase 4 Inhibitor [phsu]
alogliptin [orch, phsu]
Area [geoa]
Covered [ftcn]
Extensive [qlco]
Literature [inpr]
search [inpr]
Performed [ftcn]
Pharmacokinetics [phsf]
pioglitazone [orch, phsu]
alogliptin [orch, phsu]
Combination [qlco]
Toxicological [ftcn]
considerations [fndg]
Combined therapy [topp]
Expert Opinion [cnce]
pioglitazone [orch, phsu]
Insulin [aapp, horm, phsu]
alogliptin [orch, phsu]
Incretin [aapp, horm, phsu]
Based [ftcn]
Agent [chvf]
post meal [tmco]
insulin secretion [celf]
glucagon secretion [celf]
Mechanisms [ftcn]
Action [ftcn]
Efficacy [qlco]
Combined therapy [topp]
Superior [spco]
Single [popg]
therapy [ftcn]
Patients [podg]
treated [topp]
Diet [food]
Metformin [orch, phsu]
Sulfonylurea [orch, phsu]
Drugs [phsu]
Administered [ftcn]
Once daily [tmco]
Meal [dora]
Relevant [qlco]
PHARMACOKINETIC [resa]
Interaction [ftcn]
Agent [chvf]
Fixed [fndg]
Dose [qnco]
Combination [qlco]
Bioequivalence [qlco]
alogliptin [orch, phsu]
pioglitazone [orch, phsu]
GIVEN [cnce]
Combine [mnob]
alogliptin [orch, phsu]
pioglitazone [orch, phsu]
Altered [ftcn]
Safety [hcpp]
Profile [lbpr]
Compound [qlco]
Weight Gain [fndg]
Observed [ftcn]
pioglitazone [orch, phsu]
Limited [ftcn]
Addition [ftcn]
alogliptin [orch, phsu]
Concern [idcn]
Increased [qnco]
Heart failure [dsyn]
investigated [ftcn]
